Cannabis and the Liver: What THC Does to Metabolism
The liver is the central organ for THC metabolism. For long-term users and medical cannabis patients, the question arises: Does cannabis sustainably burden the liver or other organs? What research shows and who needs particular caution.
Overview
hide
THC metabolism in the liver: The metabolic pathway
After inhalation or oral intake, THC enters the bloodstream and is metabolized in the liver:
- First-Pass Effect (oral): With oral intake (oil, capsules, edibles), THC passes completely through the liver before entering the bloodstream. During this process, 11-Hydroxy-THC (11-OH-THC) is formed — a significantly more potent compound than THC itself, which better crosses the blood-brain barrier.
- CYP enzymes: THC is mainly metabolized by CYP3A4 and CYP2C9 — the same enzymes that break down many medications. Interactions occur when medications and THC compete for these enzymes.
- Metabolites: THC → 11-OH-THC (active, potent) → 11-COOH-THC (inactive, main metabolite in urine for drug tests)
- Excretion: 80–90% via feces (biliary), 10–20% via urine. The slow excretion explains the prolonged detectability in urine.
Elevated Liver Values with Cannabis Use
Regular cannabis use can affect liver values:
- Some studies show mild increases in ALT and AST (liver enzymes) in regular users — usually in the clinically irrelevant range
- Especially with high-dose CBD: In clinical CBD studies (epidiolex), relevant transaminase increases were observed in up to 10% of patients — mostly reversible after discontinuation
- Chronic high-dose THC consumption over years: Associated with liver diseases in individual cases, but causality remains unclear (confounders like alcohol)
- Cannabinoid Hyperemesis Syndrome (CHS) — severe cyclic vomiting in long-term high-dose users — indirectly affects organ function due to repeated vomiting
Existing Liver Diseases: Special Caution
With existing liver diseases, cannabis use should be considered particularly carefully:
- Non-alcoholic fatty liver disease (NAFLD): Cannabis use (especially daily) is associated with increased NAFLD prevalence in population-based studies — causality is uncertain, but risk is present
- Hepatitis C: Moderate cannabis use is associated with progression of fibrosis in some studies — moderate to heavy use should be discussed with the treating physician in patients with hepatitis C
- Cirrhosis: Severe liver insufficiency significantly slows down the metabolism of THC — dose adjustment is mandatory, regular doses lead to明显 enhanced and prolonged effects
- Drug interactions: In liver diseases requiring medication (immunosuppressants, antifibrotics), special attention should be paid to CYP interactions
Related
Cannabis and Kidneys: What Applies?
The kidneys are less directly affected than the liver:
- Cannabis has no direct nephrotoxic (kidney-damaging) effect — in contrast to NSAIDs or certain antibiotics
- THC metabolites are excreted via urine in 10–20%, which does not harm the kidneys
- Dehydration risk: Cannabis can cause dry mouth and reduced thirst — chronic dehydration is a risk factor for kidney stones and kidney function disorders
- Cannabis for overactive bladder (OAB): CB1 receptors in the bladder epithelium are modulated by cannabinoids — in studies, cannabis reduces bladder contractions. Some MS patients use cannabis specifically for this effect.
- Cannabis smoking (burning) is indirectly nephrologically relevant due to an increased risk of chronic kidney disease in long-term tobacco smokers
Lungs: The underestimated aspect of inhalation
Inhalation is the most common form of consumption — what happens in the lungs:
- Regular smoking of cannabis (burning) causes chronic bronchitis, coughing, and mucus production — similar to tobacco smoke
- Vaporizers (e-cigarettes) significantly reduce these risks — hot air instead of burning
- Lung cancer risk from cannabis alone: The scientific evidence is mixed and unclear — no clear link like with tobacco, but no zero risk
- Aspergillus risk: Mold spores on cannabis material can cause severe lung infections (aspergillosis) in immunocompromised individuals
Practical Recommendations for Long-Term Users
- Liver check: With regular, daily use over months — blood test (ALT, AST, GGT) at the general practitioner is recommended
- Drink enough water: Be aware of dehydration risk from cannabis — at least 2 liters of water daily
- Discuss pre-existing conditions: Existing liver or kidney disease + cannabis = always consult a doctor
- Minimiere die Einatmung: Verwende Verdampfer anstelle von Verbrennung für die Gesundheit der Lunge und der gesamten Organe
THC metabolism and interactions with medications via CYP enzymes:
Common questions about cannabis and organ health
Related
Cannabis for restless legs: CBD, dopamine & studies
Cannabis & bones: CB2, osteoporosis & bone healing
Cannabis & testosterone: effect on male fertility
Cannabis quality: laboratory tests, pesticides & contamination
Home cannabis cultivation: rules according to CanG
Cannabis microdosing: low doses of THC & CBD
More
CBN (cannabinol): Sleep sedative & effect explained
Cannabis for ADHD: THC, CBD & concentration - Studies
CBG (cannabigerol): effect, studies & application
Cannabis decarboxylation: activating THCA to THC
Cannabis in sport: CBD, regeneration & doping test
Cannabis & heart: cardiovascular risks explained
THC tolerance: how it develops and how to reduce it
Cannabis & immune system: CB2 receptors & inflammation
Cannabis in palliative care: pain & quality of life
Delta-8-THC & Delta-10-THC: Effect, difference & law
